Advertisement
Lipella Pharma Soars 48% After FDA Oks IND For LP-310 For Oral Lichen Planus
(RTTNews) - Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced Friday that the U.S. Food and Drug Administration (FDA) has approved an Investigational New Drug (IND) application for a multi-center, phase-2a, dose-escalation clinical trial.
The trial will assess the safety and efficacy of LP-310 in patients with symptomatic oral lichen planus (OLP), a highly morbid condition with no effective treatment.
In March 2023, Lipella created a five-member Scientific Advisory Board in Oral Health, made up of a group of highly regarded experts in oral medicine, to focus on the development of LP-310.
read more
Lipella Pharma Announces Top Line Results In Phase 2A Trial Of LP-10 For Hemorrhagic Cystitis
Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced top line results for its recently completed Phase 2a clinical trial evaluating the safety and efficacy of its drug candidate LP-10 for Hemorrhagic Cystitis, a rare but highly morbid disease for which there are currently no FDA approved treatments.
RTTNews
|
861日前
Pound Advances After U.K. Inflation Data
The pound was higher against its major counterparts in the New York session on Wednesday, after data showing an acceleration in consumer price inflation in the month of April.
RTTNews
|
2時34分前
Canadian Market Turns Weak, Set To Snap 10-session Winning Streak
After ten straight days of gains, the Canadian market is down in negative territory Wednesday afternoon, weighed down by losses in healthcare, technology, real estate and consumer discretionary sectors.
RTTNews
|
3時33分前
Swiss Markets Ends Modestly Lower
The Switzerland market ended lower on Wednesday after languishing in negative territory right through the day's trading session, as concerns about trade and geopolitical uncertainty rendered the mood cautious, prompting investors to refrain from making significant moves.
RTTNews
|
4時14分前
European Stocks Close On Mixed Note Amid Geopolitical, Trade Uncertainty
European stocks turned in a mixed performance on Wednesday after a cautious session as investors awaited clarity on the trade front. The impasse in Ukraine peace talks and data showing a bigger than expected increase in UK inflation weighed on sentiment.
A downward revision in U.S. federal deficit weighed as well.
RTTNews
|
4時52分前
Bay Street Seen Opening On Mixed Note
Canadian shares are likely to open on a mixed note Wednesday morning. Weak European stocks, concerns about U.S. debt, impasse over peace talks and a lack of progress in trade negotiations may weigh on sentiment.
Firm bullion and crude oil prices could trigger buying in resources sectors and limit market's downside.
RTTNews
|
9時32分前
UK Inflation Strongest Since Early 2024 On Household Bills, Employer Tax
UK consumer price inflation accelerated sharply to the highest level in more than a year in April due to higher domestic bills and the hike in employers' taxes, official data revealed on Wednesday. The consumer price index rose by a bigger-than-expected 3.5 percent year-on-year in April, which was faster than the 2.6 percent increase in March, the Office for National Statistics reported.
RTTNews
|
10時22分前
FTSE 100 Down Marginally As Investors Focus On Inflation Data, Earnings
U.K. stocks are marginally down on Wednesday amid concerns over an impasse in Russia-Ukraine peace talks, a lack of progress in trade negotiations, and data showing an acceleration in British consumer price inflation in the month of April.
Investors are also reacting to some corporate earnings announcements.
RTTNews
|
10時29分前
